The Inhibitory Activity of Mischarytera lauteriana (F.M.Bailey) Leaf Extracts against a Panel of Bacterial Pathogens

groupview

Abstract
Pharmacognosy Communications,2019,9,2,47-53.
Published:April 2019
Type:Original Article

The Inhibitory Activity of Mischarytera lauteriana (F.M.Bailey) Leaf Extracts against a Panel of Bacterial Pathogens

Lindiwe Mpala1, Getmore Chikowe1, Ian Edwin Cock1,2,*

1School of Environment and Science, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland, AUSTRALIA.

2Environmental Futures Research Institute, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland, AUSTRALIA.

Abstract:

Introduction: The development of multi-antibiotic resistant strains of bacteria has necessitated the search for new, effective antibacterial therapies. M. lauteriana was used by Australian Aborigines as a nutritious food. However, very little research has been published on this species and the antibacterial activity of M. lauteriana leaf extracts has not yet been reported. Methods: The ability of M. lauteriana leaf extracts to inhibit the growth of gram-negative and gram-positive bacterial species was investigated by disc diffusion and growth time course assays. The growth inhibitory activity was further quantified by MIC determination. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: The methanolic and aqueous M. lauteriana leaf extracts were good inhibitors of the growth of both gram-positive and gram-negative bacteria. The methanolic extract was a particularly good inhibitor of K. pneumoniae and B. cereus growth, with MIC values of 728 and 515μg/mL respectively. The aqueous extract was also a good inhibitor of these bacteria (MICs of 953 and 860μg/mL respectively). Whilst the M. lauteriana leaf extracts also inhibited the growth of P. mirabilis, S. aureus and S. pyogenes, the MIC values (in the range 1000-2000μg/mL) were indicative of moderate inhibitory activity. The M. lauteriana leaf extracts were further investigated by growth time course assays against K. pneumoniae and B. cereus. Interestingly, both extracts showed significant growth inhibition within 1h of exposure against both bacterial species. All extracts were determined to be nontoxic in the Artemia franciscana nauplii bioassay, indicating their safety for the treatment of gram-positive bacterial infections. Conclusion: The lack of toxicity of the M. lauteriana leaf extracts and their growth inhibitory bioactivity against multiple bacteria indicate their potential in the development of new antibiotic chemotherapies.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.